Loading clinical trials...
Loading clinical trials...
A Prospective, Sham-Controlled, Safety and Efficacy Study of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Modulation and Digital Health System With Objective Confirmation of Nerve Activation for Use in Home by Subjects With Overactive Bladder Syndrome
Conditions
Interventions
Avation System
Sham Avation System
Locations
6
United States
Eclipse Clinical Research
Tucson, Arizona, United States
Women's Health Institute
Oak Lawn, Illinois, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
Regional Urology
Shreveport, Louisiana, United States
Flourish Research
San Antonio, Texas, United States
Tranquil Medical Rsearch
Webster, Texas, United States
Start Date
April 14, 2022
Primary Completion Date
July 1, 2023
Completion Date
July 1, 2023
Last Updated
May 29, 2024
NCT06789406
NCT05362292
NCT07247136
NCT07193407
NCT07195656
NCT07209397
Lead Sponsor
Avation Medical, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions